Qureshi Z, Jamil A, Wali N, Okobi TJ, et al. Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Am J Clin Oncol 2026 Jan 6. doi: 10.1097/COC.0000000000001294.
PMID: 41498288